Orphelia Pharma
2Patents
2Active
2Granted
39Portfolio score
Filing activity: Mar 10, 2016 → Dec 13, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11730732B2 | Oral suspension of temozolomide | Human Necessities | 0 | Active |
| US10813898B2 | Solid dosage forms of vigabatrin | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.